Table 3 Comparison of previous studies on CD58 – MS/NMO association
From: CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population
Reference | Study populations | Study subjects | Study allele | ||
|---|---|---|---|---|---|
(case/control) | rs12044852 | rs1335532 | rs2300747 | ||
P-value(OR) | P-value(OR) | P-value(OR) | |||
Hafler et al. (2007) [13] | US and UK (MS) | 2322/5418 (1540 family trios) | 1.9 × 10 −5 (1.24) | - | - |
Rubio et al. (2008) [16] | Australia (MS) | 1134/1265 | 0.042 (1.20) | - | - |
Bahlo et al. (2009) [18]* | Australia, NZ, UK, and US (MS) | 3874/5723 | - | 9.6 × 10 −8 (1.28) | - |
De Jager et al. (2009) [17]* | US, UK, Belgium, Japanese, Chinese, and Finland (MS) | 3558/4420 (1768 family trios) | - | - | 1.1 × 10 −6 (1.22) |
Brynedal et al. (2009) [28]* | Swedish (MS) | 1077/1217 | 4.3 × 10 −4 (1.39) | - | - |
Qiu et al. (2013) [29] | Australia (MS) | 350/498 | - | - | 0.093 (1.56) |
Present study | Korean (NMO) | 99/237 | 0.004 (1.80) | 0.002 (1.87) | 0.007 (1.73) |